These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9877510)

  • 21. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
    Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
    Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles.
    Wang Z; White PS; Petrovic M; Tatum OL; Newman LS; Maier LA; Marrone BL
    J Immunol; 1999 Aug; 163(3):1647-53. PubMed ID: 10415070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of genetic and exposure factors in the prevalence of berylliosis.
    Richeldi L; Kreiss K; Mroz MM; Zhen B; Tartoni P; Saltini C
    Am J Ind Med; 1997 Oct; 32(4):337-40. PubMed ID: 9258386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity.
    Rosenman KD; Rossman M; Hertzberg V; Reilly MJ; Rice C; Kanterakis E; Monos D
    Occup Environ Med; 2011 Jul; 68(7):487-93. PubMed ID: 21186201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the berylliosis-associated HLA-DPGlu69 supratypic variant in determining the response to beryllium in a blood T-cells beryllium-stimulated proliferation test.
    Amicosante M; Deubner D; Saltini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Oct; 22(3):175-9. PubMed ID: 16315779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.
    Snyder JA; Weston A; Tinkle SS; Demchuk E
    Environ Health Perspect; 2003 Nov; 111(15):1827-34. PubMed ID: 14630515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity.
    Fontenot AP; Kotzin BL
    Tissue Antigens; 2003 Dec; 62(6):449-58. PubMed ID: 14617028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell recognition in chronic beryllium disease.
    Amicosante M; Fontenot AP
    Clin Immunol; 2006 Nov; 121(2):134-43. PubMed ID: 16697706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beryllium sensitivity is linked to HLA-DP genotype.
    Wang Z; Farris GM; Newman LS; Shou Y; Maier LA; Smith HN; Marrone BL
    Toxicology; 2001 Aug; 165(1):27-38. PubMed ID: 11551429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metal-induced diffuse lung disease.
    Fontenot AP; Amicosante M
    Semin Respir Crit Care Med; 2008 Dec; 29(6):662-9. PubMed ID: 19221964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk estimation and value-of-information analysis for three proposed genetic screening programs for chronic beryllium disease prevention.
    Bartell SM; Ponce RA; Takaro TK; Zerbe RO; Omenn GS; Faustman EM
    Risk Anal; 2000 Feb; 20(1):87-99. PubMed ID: 10795342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic pulmonary berylliosis: a model of interaction between environment and genetic predisposition (Part 1). Mineralogy, toxicology, epidemiology and risk factors].
    Marchand-Adam S; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):257-69. PubMed ID: 16092164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
    Marchand-Adam S; Guillon F; Brauner M; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
    Newman LS
    Science; 1993 Oct; 262(5131):197-8. PubMed ID: 8105535
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunology of chronic beryllium disease.
    Samuel G; Maier LA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
    Fontenot AP; Falta MT; Kappler JW; Dai S; McKee AS
    J Immunol; 2016 Jan; 196(1):22-7. PubMed ID: 26685315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease.
    Silver K; Sharp RR
    J Occup Environ Med; 2006 Apr; 48(4):434-43. PubMed ID: 16607200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and exposure risks for chronic beryllium disease.
    Maier LA
    Clin Chest Med; 2002 Dec; 23(4):827-39. PubMed ID: 12516537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
    Fontenot AP; Newman LS; Kotzin BL
    Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.